\begin{table}[htbp]\centering\begin{tabular}{lccc}\hline
Characteristic & Good Outcome & Poor Outcome & P-value \\
\hline
Number of patients & 1404 & 744 & \\

\makecell[l]{Outcome} & $12.93 \pm 21.35$ & $629.99 \pm 448.08$ & 0.000 $\uparrow$ \\

\makecell[l]{Gender} & 0: 85.6\%, 1: 14.4\% & 0: 77.6\%, 1: 22.4\% & 0.000  \\

\makecell[l]{First Visit Age} & $23.18 \pm 21.76$ & $22.13 \pm 23.01$ & 0.297  \\

\makecell[l]{CI nd U} & 0: 99.6\%, 1: 0.4\% & 0: 98.5\%, 1: 1.5\% & 0.009  \\

\makecell[l]{Lymphocytes Percentage \\ chronic} & $35.25 \pm 9.20$ & $36.53 \pm 11.95$ & 0.006 $\uparrow$ \\

\makecell[l]{Lymphocytes Percentage \\ preclinical} & $37.82 \pm 14.39$ & $40.38 \pm 15.15$ & 0.000 $\uparrow$ \\

\makecell[l]{Lymphocytes Percentage \\ acute} & $32.02 \pm 14.20$ & $34.68 \pm 13.92$ & 0.000 $\uparrow$ \\

\makecell[l]{Neutrophils Percentage \\ chronic} & $54.50 \pm 10.04$ & $53.69 \pm 12.76$ & 0.106  \\

\makecell[l]{Neutrophils Percentage \\ preclinical} & $51.50 \pm 15.90$ & $48.89 \pm 16.49$ & 0.000 $\downarrow$ \\

\makecell[l]{Neutrophils Percentage \\ acute} & $60.06 \pm 15.84$ & $56.89 \pm 14.86$ & 0.000 $\downarrow$ \\

\makecell[l]{Monocytes Percentage \\ preclinical} & $6.67 \pm 1.06$ & $6.70 \pm 0.82$ & 0.520  \\

\makecell[l]{Monocytes Percentage \\ chronic} & $6.54 \pm 0.72$ & $6.52 \pm 1.21$ & 0.748  \\

\makecell[l]{Monocytes Percentage \\ acute} & $6.22 \pm 1.10$ & $6.23 \pm 1.04$ & 0.894  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration chronic} & $333.85 \pm 4.45$ & $334.02 \pm 8.74$ & 0.531  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration acute} & $336.46 \pm 11.31$ & $338.60 \pm 12.87$ & 0.000 $\uparrow$ \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin \\ Concentration \\ preclinical} & $343.00 \pm 6.89$ & $343.89 \pm 7.39$ & 0.005 $\uparrow$ \\

\makecell[l]{Platelet Count chronic} & $253.05 \pm 31.33$ & $257.79 \pm 57.16$ & 0.013  \\

\makecell[l]{Platelet Count acute} & $258.49 \pm 66.25$ & $258.91 \pm 62.17$ & 0.886  \\

\makecell[l]{Platelet Count \\ preclinical} & $251.61 \pm 49.27$ & $255.57 \pm 49.78$ & 0.077  \\

\makecell[l]{White Blood Cell Count \\ acute} & $10.18 \pm 3.21$ & $9.57 \pm 2.56$ & 0.000 $\downarrow$ \\

\makecell[l]{White Blood Cell Count \\ preclinical} & $8.55 \pm 1.91$ & $8.53 \pm 1.81$ & 0.812  \\

\makecell[l]{White Blood Cell Count \\ chronic} & $8.45 \pm 0.90$ & $8.67 \pm 2.32$ & 0.001 $\uparrow$ \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin preclinical} & $28.46 \pm 1.68$ & $28.29 \pm 1.73$ & 0.024  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin acute} & $28.60 \pm 1.96$ & $28.63 \pm 2.04$ & 0.702  \\

\makecell[l]{Mean Corpuscular \\ Hemoglobin chronic} & $28.96 \pm 1.39$ & $28.79 \pm 1.75$ & 0.012  \\

\makecell[l]{Mean Corpuscular Volume \\ acute} & $85.04 \pm 6.27$ & $84.55 \pm 5.80$ & 0.080  \\

\makecell[l]{Mean Corpuscular Volume \\ chronic} & $86.69 \pm 4.22$ & $86.00 \pm 5.26$ & 0.001 $\downarrow$ \\

\makecell[l]{Mean Corpuscular Volume \\ preclinical} & $83.14 \pm 5.56$ & $82.41 \pm 5.82$ & 0.005 $\downarrow$ \\

\makecell[l]{Hemoglobin preclinical} & $128.16 \pm 6.98$ & $127.18 \pm 8.30$ & 0.004 $\downarrow$ \\

\makecell[l]{Hemoglobin acute} & $129.27 \pm 9.43$ & $129.40 \pm 7.92$ & 0.754  \\

\makecell[l]{Hemoglobin chronic} & $130.33 \pm 4.71$ & $129.83 \pm 7.45$ & 0.057  \\

\makecell[l]{Eosinophils Percentage \\ acute} & $1.61 \pm 1.97$ & $1.60 \pm 1.71$ & 0.924  \\

\makecell[l]{Eosinophils Percentage \\ chronic} & $2.24 \pm 1.17$ & $2.29 \pm 1.88$ & 0.415  \\

\makecell[l]{Eosinophils Percentage \\ preclinical} & $2.72 \pm 2.47$ & $2.74 \pm 2.41$ & 0.901  \\

\makecell[l]{Basophils Percentage \\ preclinical} & $0.27 \pm 0.13$ & $0.27 \pm 0.14$ & 0.822  \\

\makecell[l]{Basophils Percentage \\ acute} & $0.21 \pm 0.17$ & $0.22 \pm 0.17$ & 0.038  \\

\makecell[l]{Basophils Percentage \\ chronic} & $0.30 \pm 0.13$ & $0.30 \pm 0.21$ & 0.984  \\

\makecell[l]{Absolute Eosinophil \\ Count preclinical} & $0.22 \pm 0.31$ & $0.23 \pm 0.31$ & 0.520  \\

\makecell[l]{Absolute Eosinophil \\ Count chronic} & $0.18 \pm 0.11$ & $0.18 \pm 0.16$ & 0.293  \\

\makecell[l]{Absolute Eosinophil \\ Count acute} & $0.14 \pm 0.17$ & $0.14 \pm 0.16$ & 0.896  \\

\makecell[l]{Absolute Lymphocyte \\ Count preclinical} & $3.11 \pm 1.25$ & $3.35 \pm 1.44$ & 0.000 $\uparrow$ \\

\makecell[l]{Absolute Lymphocyte \\ Count acute} & $2.96 \pm 1.27$ & $3.03 \pm 1.29$ & 0.238  \\

\makecell[l]{Absolute Lymphocyte \\ Count chronic} & $2.67 \pm 0.85$ & $2.86 \pm 1.10$ & 0.000 $\uparrow$ \\

\makecell[l]{Mean Platelet Volume \\ preclinical} & $9.54 \pm 0.81$ & $9.51 \pm 0.79$ & 0.491  \\

\makecell[l]{Mean Platelet Volume \\ chronic} & $9.08 \pm 0.87$ & $9.21 \pm 1.21$ & 0.005 $\uparrow$ \\

\makecell[l]{Mean Platelet Volume \\ acute} & $9.87 \pm 1.14$ & $9.60 \pm 1.10$ & 0.000 $\downarrow$ \\

\makecell[l]{Platelet Distribution \\ Width acute} & $12.02 \pm 2.06$ & $11.85 \pm 1.79$ & 0.055  \\

\makecell[l]{Platelet Distribution \\ Width preclinical} & $11.88 \pm 1.48$ & $11.75 \pm 1.60$ & 0.056  \\

\makecell[l]{Platelet Distribution \\ Width chronic} & $12.08 \pm 1.18$ & $12.05 \pm 1.74$ & 0.656  \\

\makecell[l]{Eosinophil Count \\ Absolute chronic} & $175.76 \pm 86.27$ & $183.94 \pm 141.13$ & 0.096  \\

\makecell[l]{Eosinophil Count \\ Absolute acute} & $124.29 \pm 119.74$ & $124.51 \pm 126.18$ & 0.968  \\

\makecell[l]{Eosinophil Count \\ Absolute preclinical} & $223.54 \pm 146.77$ & $247.10 \pm 273.23$ & 0.009 $\uparrow$ \\

\makecell[l]{CR eactive Protein \\ preclinical} & $8.73 \pm 6.87$ & $8.82 \pm 7.17$ & 0.793  \\

\makecell[l]{CR eactive Protein \\ acute} & $10.51 \pm 12.28$ & $8.95 \pm 8.23$ & 0.002 $\downarrow$ \\

\makecell[l]{CR eactive Protein \\ chronic} & $5.22 \pm 3.78$ & $6.45 \pm 8.80$ & 0.000 $\uparrow$ \\

\makecell[l]{Immunoglobulin E \\ chronic} & $216.18 \pm 161.80$ & $219.73 \pm 445.20$ & 0.789  \\

\makecell[l]{Immunoglobulin E acute} & $147.18 \pm 101.97$ & $166.40 \pm 113.34$ & 0.000 $\uparrow$ \\

\makecell[l]{Free Thyroxine chronic} & $16.14 \pm 0.81$ & $16.21 \pm 1.04$ & 0.058  \\

\makecell[l]{Free Thyroxine acute} & $15.40 \pm 0.75$ & $15.30 \pm 0.79$ & 0.007 $\downarrow$ \\

\makecell[l]{SMRNP acute} & $1.32 \pm 0.82$ & $1.38 \pm 0.59$ & 0.109  \\

\makecell[l]{SMRNP chronic} & $1.19 \pm 0.76$ & $1.24 \pm 0.69$ & 0.177  \\

\makecell[l]{Anti SSA chronic} & $1.27 \pm 2.59$ & $1.40 \pm 2.79$ & 0.294  \\

\makecell[l]{Anti SSA acute} & $1.08 \pm 2.62$ & $1.25 \pm 4.30$ & 0.234  \\

\makecell[l]{Anti Jo 1 chronic} & $1.06 \pm 0.92$ & $1.07 \pm 0.45$ & 0.955  \\

\makecell[l]{Anti Jo 1 acute} & $0.82 \pm 0.42$ & $0.84 \pm 0.43$ & 0.316  \\

\makecell[l]{Nucleosome acute} & $1.15 \pm 0.75$ & $1.12 \pm 0.72$ & 0.373  \\

\makecell[l]{Nucleosome chronic} & $0.53 \pm 0.42$ & $0.55 \pm 0.46$ & 0.477  \\

\makecell[l]{Ribosomal PP rotein \\ chronic} & $1.15 \pm 0.23$ & $1.30 \pm 3.20$ & 0.090  \\

\makecell[l]{Ribosomal PP rotein \\ acute} & $1.08 \pm 0.27$ & $1.10 \pm 0.29$ & 0.184  \\

\makecell[l]{Ro 52 acute} & $1.80 \pm 1.90$ & $1.91 \pm 4.33$ & 0.393  \\

\makecell[l]{Ro 52 chronic} & $1.79 \pm 1.78$ & $1.92 \pm 3.52$ & 0.251  \\
\hline\end{tabular}\caption{Comparison of the characteristics between patients with good and poor outcomes in the time dependent dataset \\ continuous variables are presented as mean Â± standard deviation, categorical variables are presented as number (percentage) \\ good outcome is defined as visit duration < 100 days, poor outcome is defined as visit duration $\geq$ 100 days} \label{tab:good_outcome_poor_outcome_time}
\end{table}